Merck (MRCG.DE), a German pharmaceutical company, said on Monday that Helene von Roeder would replace Marcus Kuhnert as CFO and a member of the Executive Board.

The business said the adjustments will take effect on July 1.

This month, German real estate firm Vonovia (VNAn.DE) stated that von Roeder would be voluntarily stepping down from the company’s management board from July 1.

Share.

I'm Anna Kovalenko, a business journalist with a passion for writing about the latest trends and innovations in the corporate world. From tech startups to multinational corporations, I love nothing more than exploring the latest developments and sharing my insights with readers.

© 2026 All right Reserved By Biznob.